20409 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two nitrogen atoms as the only ring heteroatoms, e.g. piperazine Non-condensed pyrazines
Therapeutic Indications of Kinase Inhibitors
#602Radiosensitizer compounds for use in combination with radiation
#603Pyrazine derivatives and uses thereof in renal monitoring
#604ANTIVIRAL COMPOUNDS AND METHODS
#6053,5-diamino-6-chloro-N-(n-(4-phenylbutyl)carbamimidoyl)pyrazine-2-carboxamide compounds
#606Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity
#607Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
#608Treatment of Cancer with Glufosfamide in Patients Not Receiving Insulin Therapy
#609PULMONARY DISEASE-SPECIFIC THERAPEUTIC AGENT
#610Endoparasite control agent
#611Form-III crystal of 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide and use thereof
#612Compounds for inflammation and immune-related uses
#613Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomapathies
#614Pharmaceutical compositions comprising sorbitan esters
#615METALLOENZYME INHIBITOR COMPOUNDS
#616Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonists
#617Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
#618ANTITUBERCULOUS COMPOSITION COMPRISING OXAZOLE COMPOUNDS
#619Albumin fusion proteins
#620Aryloxyurea compound and pest control agent
#621Therapeutic composition including carbonated solution
#622Compositions comprising enzyme-cleavable oxycodone prodrug
#623Pharmaceutical formulations for the treatment of pulmonary arterial hypertension
#624Compositions comprising macrolide and tetracycline and their uses
#625Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof
#626HCV protease inhibitors and uses thereof
#627Arylalkyl- and aryloxyalkyl-substituted epthelial sodium channel blocking compounds
#628Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
#629Compounds and methods for inhibiting phosphate transport
#630Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
#631AEROSOL DELIVERY SYSTEMS, COMPOSITIONS AND METHODS
#632Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
#633PHARMACEUTICAL PRODUCT COMPRISING A P38 KINASE INHIBITOR AND A SECOND ACTIVE INGREDIENT
#634EARLY DETECTION OF TUBERCULOSIS TREATMENT RESPONSE
#635MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#636Aminoheteroaryl benzamides as kinase inhibitors
#637Gastric retentive tablet compositions
#638Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
#639Formulation Solution Adapted to Prolong Plasma Times of Drugs in Mammals Including Humans
#640REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#641Dithiol mucolytic agents
#642Pharmaceutical compounds
#643Pyridine and pyrazine derivative for the treatment of CF
#644Pyrazine amide compounds
#645Use of Compounds Elevating Glutathione Levels for the Treatment of Autism, Autistic Spectrum Disorders and Fragile X Syndrome
#646Meglumine salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide
#647Anti-malarial agents
#648Heterocyclic compounds, medicaments containing them, use and processes for the preparation thereof
#649Azaheterocyclic compounds
#650Method and composition for treating alzheimer-type dementia
#651Formulation Solution Adapted to Prolong Plasma Times of Drugs in Mammals Including Humans
#652Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer
#653Treating cancer with ATR inhibitors
#654Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof
#655Modulators of aldehyde dehydrogenase and methods of use thereof
#656METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER
#657Therapeutic compositions containing macitentan
#658Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
#659Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
#660Methods of treating CXCR4-expressing cancers
#661Albumin fusion proteins
#662Gene signature for the prediction of NF-kappaB activity
#663ENANTIOMERICALLY PURE AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS
#664Therapeutic compositions and methods
#665Enhanced treatment regimens using mTor inhibitors
#666Phenol derivatives and pharmaceutical or cosmetic use thereof
#667Inhibition of neovascularization by inhibition of prostanoid IP receptors
#668Inhibition of neovascularization by simultaneous inhibition of prostanoid IP and EP4 receptors
#669Substituted hydroxamic acids and uses thereof
#670COMBINATION PRODUCTS
#671Diketopiperazine salts for drug delivery and related methods
#672SODIUM CHANNEL BLOCKERS REDUCE GLUCAGON SECRETION
#673Pyruvate kinase activators for use in therapy
#674SODIUM CHANNEL BLOCKERS
#675Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity
#676Pesticidal compositions and processes related thereto
#677Pesticidal compositions and processes related thereto
#678Pesticidal compositions and processes related thereto
#679Pesticidal compositions and processes related thereto
#6803,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds
#681LYSINE DEMETHYLASE INHIBITORS FOR MYELOPROLIFERATIVE OR LYMPHOPROLIFERATIVE DISEASES OR DISORDERS
#682Compositions comprising enzyme-cleavable oxycodone prodrug
#683Amine-containing lipidoids and uses thereof
#684Form-II crystal of 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl) acetamide, method for producing the same, and use thereof
#685Pyruvate kinase activators for use in therapy
#686Use of form-I crystal of 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide
#687Specific carboxamides as KCNQ2/3 modulators
#688Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity
#689Pyridine and Pyrazine derivative for the Treatment of CF
#690Selecting use of proteasome inhibitors based on NF-κB2 sequence
#691Synthetic lethal targeting of glucose transport
#692Oral solid formulation of compound anti-tubercular drug and preparation method thereof
#693Compounds and methods for inducing chondrogenesis
#6943,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide
#695Genes Associated With Post Relapse Survival And Uses Thereof
#696Therapies for hematologic malignancies
#697ANTIHISTAMINE- AND CORTICOSTEROID-CONTAINING LIPOSOME COMPOSITION AND ITS USE FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING RHINITIS AND RELATED DISORDERS
#698Cancer diagnostics, therapeutics, and drug discovery associated with macropinocytosis
#699Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#700COMPOUND PREPARATION TREATING ALZHEIMER'S DISEASE AND PREPARATION METHOD THEREOF
#701Combination therapy to treat diseases
#702COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE AND COMBINATION THERAPIES THEREOF
#703Fluorescent pyrazine derivatives and methods of using the same in assessing renal function
#704Low side effect pharmaceutical composition containing antituberculosis drugs
#705HETEROARYL SULFONAMIDES AND CCR2/CCR9
#706Minimizing intestinal dysfunction
#707Composition for reducing nervous system injury and method of making and use thereof
#708HCV protease inhibitors and uses thereof
#709Enhancement of the action of anti-infective agents and of central and peripheral nervous system agents and transportation of nucleic acid substances
#710Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
#711Certain chemical entities, compositions and methods
#712Compounds for inflammation and immune-related uses
#713Method of regulating neuronal axon elongation
#714Biguanide derivative compound
#715METHODS FOR TREATING PULMONARY HYPERTENSION
#716Sulfonyl-substituted bicyclic compounds as PPAR modulators for the treatment of non-alcoholic steatohepatitis
#717Aryloxyurea compound and pest control agent
#718SIR2 regulation
#719Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
#720METHOD AND COMPOSITION FOR TREATING ALZHEIMER'S DISEASE AND DEMENTIAS OF VASCULAR ORIGIN
#721Treating attention deficit hyperactivity disorder with NHE inhibitors
#722NOVEL COMPOUNDS, USE AND PREPARATION THEREOF
#723Thioacetate compounds, compositions and methods of use
#724COMPOSITIONS AND METHODS FOR TREATING DIABETES AND NEUROPSYCHOLOGICAL DYSFUNCTION
#7253,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide
#726Processes for making cyclopropyl amide derivatives and intermediates associated therewith
#727Therapeutic vaccination against active Tuberculosis
#728Formulation Solution Adapted To Prolong Plasma Times Of Drugs In Mammals Including Humans
#729Anticoagulant reversal agents
#730Therapeutic compounds
#731Functionally selective ligands of dopamine Dreceptors
#732TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF METASTATIC BONE DISEASE
#733Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases
#734Methods of regulating uptake and transcellular transport of leukocytes and therapeutics
#735Treating Cancer with ATR Inhibitors
#736Methods for Treating HCV
#737GPR 119 MODULATORS
#738Pharmaceutical compounds
#739Compounds for treating disease, for administering, and for pharmaceutical compositions
#740Tuberculosis drug based on 4-thioureido-iminomethylpyridinium perchlorate: method of preparation and treatment
#741USE OF AUTOLOGOUS EFFECTOR CELLS FOR TREATMENT OF MULTIPLE MYELOMA
#742Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases
#743Type II Raf kinase inhibitors
#744Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#745Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#746Solid dispersion formulations and methods of use thereof
#747ANTIVIRAL COMPOUNDS AND METHODS
#748Methods and compositions comprising at least one α3 βA4 nAChR antagonist or pharmaceutically acceptable salt thereof
#749Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
#750Sodium channel blockers
#751CYTOTOXIC THERAPY BY PROTON FLUX MODULATION
#752Diketopiperazine salts for drug delivery and related methods
#753Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
#754Stable bortezomib formulations
#755Stable bortezomib formulations
#756Tryptophan Hydroxylase Inhibitors for the Treatment of Cancer
#757Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, Alzheimer'S disease, sleep disorders, Parkinson'S disease, AIDS, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
#758Enhancement of the action of anti-infective agents and of central and peripheral nervous system agents and transportation of nucleic acid substances
#759Combination Therapy With Organic Arsenicals
#760Inhibitor of protein crosslinking and use of the same
#761Pyridine and pyrazine derivative for the treatment of CF
#762Methods and compositions of treating a flaviviridae family viral infection
#763Methods of sensitizing drug resistant microorganisms using methylsulfonylmethane (MSM)
#764METHODS OF USING [3.2.0] HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF FOR TREATING INFECTIOUS DISEASES
#765Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
#766Pharmaceutical compositions comprising sorbitan esters
#767Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
#768NUTRIENT DELIVERY DRUG COMPOSITION
#769FUSED BICYCLIC PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF
#770PI3 kinase inhibitors
#771Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
#772HCV protease inhibitors and uses thereof
#773Substituted amide compound
#774Compositions comprising enzyme-cleavable oxycodone prodrug
#775Stable bortezomib formulations
#776Methods of Reducing Risk of Infection from Pathogens
#777Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents
#778PYRAZINAMIDE FOR IMMUNOSTIMULATION AND THE TREATMENT OF LEISHMANIASES
#779Substituted 4-hydroxypyrimidine-5-carboxamides
#780PHARMACEUTICAL CO-CRYSTALS OF QUERCETIN
#781COMPOSITIONS AND METHODS FOR TREATING NECROTIZING ENTEROCOLITIS
#782Compounds useful as inhibitors of ATR kinase
#783Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent
#784PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF SALICYLANILIDES FOR TREATMENT OF HEPATITIS VIRUSES
#785Therapeutic compositions and methods
#7862'-FLUORO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT
#787Form-I crystal of 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide and method for producing the same
#788Pyrazine derivatives and uses thereof in renal monitoring
#789ION CHANNEL MODULATING ACTIVITY II
#790Treatment of ischemia
#791METHOD FOR IMPROVING PHARMACOKINETICS OF PROTEASE INHIBITORS AND PROTEASE INHIBITOR PRECURSORS
#792Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#793METHODS OF TREATING CNS DISORDERS
#794COMPOSITIONS FOR PROTECTION AGAINST SUPERFICIAL VASODILATOR FLUSH SYNDROME, AND METHODS OF USE
#795Albumin fusion proteins
#796Pharmaceutical product comprising a p38 kinase inhibitor and a second active ingredient
#797PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION
#798Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
#799Compositions Comprising Multiple Bioactive Agents, and Methods of Using the Same
#800INHIBITION OF YOPS TRANSLOCATION
#801Treatment for spinal muscular atrophy
#802Use of lumefantrine and related compounds in the treatment of cancer
#803Optical method for detecting Alzheimer's disease by systemic administration of curcumin
#804Genes associated with post relapse survival and uses thereof
#805METHODS OF TREATING ULCERATIVE COLITIS
#806Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells
#807Kynurenine production inhibitor
#808Pyridine and pyrazine derivative for the treatment of CF
#809Stable bortezomib formulations
#810Methods for Treating Acute Myocardial Infarctions and Associated Disorders
#811NUTRIENT DELIEVRY DRUG COMPOSITION
#812SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF
#813Method for treating cognitive deficits
#814Crystalline Form Of A Cyclopropyl Benzamide Derivative
#815TREATMENT AND DIAGNOSIS OF CENTRAL NERVOUS SYSTEM DISORDERS
#816NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND
#817Application of 2,5 -dihydroxymethyl-3,6-dimethyl pyrazine and its derivates in pharmacy
#818Combination Therapy for Tuberculosis
#819STABLE SOLID ORAL DOSAGE CO-FORMULATIONS
#820Copper (1) Complex
#821Therapeutic agent for chronic renal failure
#822SIR2 regulation
#823Oral Formulation
#824Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
#825Methods of reducing risk of infection from pathogens
#8265-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine-2-carbonitrile, pharmaceutically acceptable salts thereof, or solvate of salts
#827Promoting cycling of ApoE4 isoform
#828Therapeutic compositions containing macitentan
#829Uses of ion channel modulating compounds
#830Therapeutic agent for inflammatory bowel disease
#831Heteroaryl sulfonamides and CCR2/CCR9
#832Methods of treating pulmonary hypertension
#833PAI-1 EXPRESSION AND ACTIVITY INHIBITORS FOR THE TREATMENT OF OCULAR DISORDERS
#834Therapeutic agent for spinal canal stenosis
#835COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES
#836Amino substituted pyrazines as inhibitors or protein kinases
#837Compositions and methods of use of ritonavir for treating HCV
#838FATTY ACID ACIPIMOX DERIVATIVES AND THEIR USES
#839INHIBITORS OF 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE I
#840SELECTIVELY DEPOLYMERIZED GALACTOMANNAN POLYSACCHARIDE
#841Method and composition for treating alzheimer-type dementia
#842Chemical compounds having antiviral activity against Dengue virus and other
#843Method of treating inherited severe neutropenia
#844Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
#845Capped pyrazinoylguanidine sodium channel blockers
#846Phosphodiesterase 4 inhibitors
#847NPY Y5 ANTAGONIST
#848PDE10 inhibitors and related compositions and methods
#849Fibrosis inhibitor
#850Tetrahydropyridine, tetrahydroazepine, and dihydropyrrole derivatives for inflammation and immune-related uses
#851Therapeutic Treatment Of Wounds
#852Albumin fusion proteins
#853Diketopiperazine salts for drug delivery and related methods
#854Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
#855Aminocyclohexyl ether compounds and uses thereof
#856ENANTIOMERICALLY PURE AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS
#857Therapeutic agent or prophylactic agent for inflammatory bowel disease comprising amino alcohol derivative as active ingredient
#858METHODS OF AFFECTING GASTROINTESTINAL TRANSIT AND GASTRIC EMPTYING, AND COMPOUNDS USEFUL THEREIN
#859Combination therapy with organic arsenicals
#860NPY Y5 antagonist
#861COMBINATIONS OF HCV PROTEASE INHIBITOR(S) AND CYP3A4 INHIBITOR(S), AND METHODS OF TREATMENT RELATED THERETO
#862LIPID FORMULATION OF APOPTOSIS PROMOTER
#863Ophthalmic formulations of cetirizine and methods of use
#864P-38 Kinase Inhibitors
#865New Compounds
#866AMINOPYRAZINE ANALOGS FOR TREATING GLAUCOMA AND OTHER RHO KINASE-MEDIATED DISEASES AND CONDITIONS
#867THERAPIES FOR HEMATOLOGIC MALIGNANCIES
#868PHARMACEUTICAL COMPOSITIONS AND METHOD FOR TREATING ACUTE MANIA
#869METHODS AND COMPOSITIONS COMPRISING AT LEAST ONE ALPHA3 BETA4 nAChR ANTAGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#870METHODS FOR TREATING ACUTE MYOCARDIAL INFARCTIONS AND ASSOCIATED DISORDERS
#871Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin
#872Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin
#873METHODS OF USING [3.2.0] HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF FOR TREATING INFECTIOUS DISEASES
#874Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
#875Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
#876Kinase Inhibitors, and Methods of Using and Identifying Kinase Inhibitors
#877Use of HDAC inhibitors for the treatment of myeloma
#878TREATMENT FOR SPINAL MUSCULAR ATROPHY
#879Sodium channel blockers
#880VAGINAL ODORANTS
#881Use of Tri-Substituted Glycerol Compounds for the Treatment of Hematological Malignancies
#882Ion channel modulating activity I
#883Modulators of aldehyde dehydrogenase and methods of use thereof
#884COMPOUNDS USEFUL FOR INHIBITING CHK1
#885Treatment of cancer with glufosfamide in patients not receiving insulin therapy
#886THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR DEMYELINATING DISEASE COMPRISING AMINO ALCOHOL DERIVATIVE AS ACTIVE INGREDIENT
#887Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination
#888MULTIPLE NEBULIZER SYSTEMS
#889Inhibitor for enzyme having two divalent metal ions as active center
#890HCV protease inhibitors and uses thereof
#891Certain Chemical entities, compositions and methods
#892Treatment for demyelinating disease
#893PHASE 2 INDUCERS AND RELATED SIGNALING PATHWAYS PROTECT CARTILAGE AGAINST INFLAMMATION/INFECTION, APOPTOSIS AND STRESS
#894Amino alcohol derivative and immunosuppresive agent having same as an active ingredient
#895COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES
#896METHOD FOR TREATING CARDIOVASCULAR DISEASES USING RHO KINASE INHIBITOR COMPOUNDS
#897Methods and compositions for treating platelet-related disorders
#898SUSTAINED RELEASE DOSAGE FORMS OF ZIPRASIDONE
#899Method for treating diseases associated with alterations in cellular integrity using Rho kinase inhibitor compounds
#900Antihistamine-and corticosteroid-containing lipsome composition and its use for the manufacture of medicament for treating rhinitis and related disorders